Nikos Fatsis-Kavalopoulos
nikosfk.bsky.social
Nikos Fatsis-Kavalopoulos
@nikosfk.bsky.social
Biomedical engineer working on developing new generation clinical diagnostics with a focus on infectious diseases
Have you heard about Heteroresistance? Clinical evidence of this elusive kind of antibacterial resistance is mounting. Check out our new publication on the impact of Break Point crossing Heteroresistance on treatment and patient outcomes #AMR
www.thelancet.com/journals/lan...
Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study
In a cohort of patients with E coli bloodstream infections, heteroresistance is common and frequently misidentified in routine clinical testing. Several negative effects on patient outcomes are associ...
www.thelancet.com
January 17, 2025 at 8:00 AM
Since I joined the wonderful academic community of @uppsalauniversitet.bsky.social I haven't missed any of the amazing Lucia day medicine and physiology nobel lectures. μRNAs this year were a BLAST. Thank you Gary Ruvkun.
December 13, 2024 at 9:57 AM
Reposted by Nikos Fatsis-Kavalopoulos
At a December 11 conference, Greek experts warned of pandemic risks, including H5N1 mutations, and highlighted Greece's leading antibiotic consumption in Europe, which drives high AMR and 35,000 EU deaths annually.
www.ekathimerini.com/news/1256043...
Public health threats top experts’ agenda | eKathimerini.com
Greece’s public health experts are sounding alarms about future pandemic threats and the growing issue of antibiotic resistance.
www.ekathimerini.com
December 13, 2024 at 7:43 AM
Reposted by Nikos Fatsis-Kavalopoulos
Microbiologists and infectious diseases researchers moving over from Twitter/X to BlueSky #MicroSky #IDSky #ScienceSky
November 14, 2024 at 7:20 PM
Reposted by Nikos Fatsis-Kavalopoulos
Continuing with more #diagnostics & #AST, but expanding to #combinations! Many times infections are treated with several #antibiotics, but how well do these combinations actually work?
@nikosfk.bsky.social & YK Kim present their most up to date results using CombiANT plates.
November 14, 2024 at 2:47 AM
Reposted by Nikos Fatsis-Kavalopoulos
antibiotic resistance, antimicrobial resistance, AMR:
Incredible graphic - the myriad of ways that bacteria defend themselves against antibiotics.

14 resistance mechanisms, summarised by Idan Yelin & Roy Kishony in Cell

www.sciencedirect.com/science/arti...
November 13, 2024 at 5:54 PM
Thank you @bachmanntill.bsky.social for putting POC diagnostics for #AMR into a proper perspective for everyone here in #Brainlink_2024_X-lab_day
November 14, 2024 at 12:37 AM
Reposted by Nikos Fatsis-Kavalopoulos
Moving onto our final big event of this trip: BrainLink X-Lab Day Symposium on New Initiatives for Collaborative Research on Global #AMR!

Train to Busan (no zombies tho! 🧟) in great company with @bachmanntill.bsky.social, YK Kim, Dan Andersson, @nikosfk.bsky.social & @evagaresp.bsky.social
November 13, 2024 at 8:08 AM
Reposted by Nikos Fatsis-Kavalopoulos
Hi there #blueworld! We are expanding our presence on the social platforms and want to connect with you here as well! We are a center for #research & #education on #antibiotics, #antibioticresistance & #AMR at Uppsala University.

Looking forward to connect and grow with all of you, join us! 🙌🏻
November 12, 2024 at 6:41 AM
Great work @evagaresp.bsky.social on introducing the @uac-uu.bsky.social and all the important work we do in fighting #AMR. Great to see our colleagues in the Hallam medical center found the very first antibiotic center in Korea, proud to be part of this collaborative effort
November 13, 2024 at 1:51 AM